Hippocratic AI, a healthcare-focused AI company, has raised $141 million in its Series B financing round, bringing its valuation to $1.64 billion. The funding was led by Kleiner Perkins, with participation from existing investors including Andreessen Horowitz, General Catalyst, NVIDIA, and Universal Health Services. This marks a significant milestone for the company, which raised the capital just nine months after completing its Series A round. The funds will support the company’s mission to enhance healthcare accessibility through its Polaris constellation LLM architecture and expand into new verticals like pharmaceuticals and insurance, as well as markets in Europe, Southeast Asia, and Latin America.
The company has demonstrated notable progress in recent months, achieving safety parity between its AI agents and human clinicians and launching its Polaris 2.0 model, which features 3.7 trillion parameters. Hippocratic AI has also partnered with health systems such as UHS, WellSpan Health, and OhioHealth, completing hundreds of thousands of patient interactions that have earned an average satisfaction rating of 8.7 out of 10. Co-Founder and CEO Munjal Shah highlighted the company’s achievements, including signing contracts with 23 healthcare organizations in 23 weeks. He said, "This round of financing will accelerate the development and deployment of the Hippocratic GenAI-driven super staffing and continue our quest to make healthcare abundance a reality."
